African Trypanosomiasis Global Clinical Trials Review, H2, 2014
Summary
GlobalData's clinical trial report, “African Trypanosomiasis Global Clinical Trials Review, H2, 2014" provides data on the African Trypanosomiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on African Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating African Trypanosomiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
African Trypanosomiasis 4
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in Europe 9
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 10
Clinical Trials by G7 Countries: Proportion of African Trypanosomiasis to Infectious Disease Clinical Trials 11
Clinical Trials in G7 Countries by Trial Status 12
Clinical Trials by Phase 13
Clinical Trials by Trial Status 14
Clinical Trials by End Point Status 15
Unaccomplished Trials of African Trypanosomiasis 16
Subjects Recruited Over a Period of Time 17
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in African Trypanosomiasis Therapeutics Clinical Trials 20
Prominent Drugs 21
Clinical Trial Profiles 22
Clinical Trial Overview of Top Companies 22
Immtech Pharmaceuticals, Inc. 22
Clinical Trial Overview of Immtech Pharmaceuticals, Inc. 22
KT&G Corporation 23
Clinical Trial Overview of KT&G Corporation 23
Clinical Trial Overview of Top Institutes / Government 24
Drugs for Neglected Diseases initiative 24
Clinical Trial Overview of Drugs for Neglected Diseases initiative 24
Epicentre Biotechnologies 25
Clinical Trial Overview of Epicentre Biotechnologies 25
United Nations International Children's Emergency Fund 26
Clinical Trial Overview of United Nations International Children's Emergency Fund 26
Five Key Clinical Profiles 27
Appendix 44
Abbreviations 44
Definitions 44
Research Methodology 45
Secondary Research 45
About GlobalData 46
Contact Us 46
Disclaimer 46
Source 46
List Of Tables
List of Tables
African Trypanosomiasis Therapeutics, Global, Clinical Trials by Region, 2014* 5
African Trypanosomiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 6
African Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 7
African Trypanosomiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 8
African Trypanosomiasis Therapeutics Clinical Trials, Europe, Top Countries, 2014* 9
African Trypanosomiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 10
Proportion of African Trypanosomiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 11
African Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
African Trypanosomiasis Therapeutics, Global, Clinical Trials by Phase, 2014* 13
African Trypanosomiasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
African Trypanosomiasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
African Trypanosomiasis Therapeutics, Global, Terminated Clinical Trials, 2014* 16
African Trypanosomiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 17
African Trypanosomiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 18
African Trypanosomiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 19
African Trypanosomiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 20
African Trypanosomiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 21
African Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immtech Pharmaceuticals, Inc., 2014* 22
African Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by KT&G Corporation, 2014* 23
African Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Drugs for Neglected Diseases initiative, 2014* 24
African Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Epicentre Biotechnologies, 2014* 25
African Trypanosomiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by United Nations International Children's Emergency Fund, 2014* 26
List Of Figures
List of Figures
African Trypanosomiasis Therapeutics, Global, Clinical Trials by Region (%), 2014* 5
African Trypanosomiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 6
African Trypanosomiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 7
African Trypanosomiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 10
Proportion of African Trypanosomiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 11
African Trypanosomiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
African Trypanosomiasis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 13
African Trypanosomiasis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
African Trypanosomiasis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
African Trypanosomiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 17
African Trypanosomiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 18
African Trypanosomiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 19
African Trypanosomiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 20
GlobalData Methodology 45
